Mycoplasma Testing Market Size Projected To Reach $1.92 Billion By 2034 With A Cagr Of 11.7%

The Mycoplasma Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Mycoplasma Testing Market Size and Projected Growth Rate?
Over the past few years, the size of the mycoplasma testing market has seen rapid growth. It is anticipated to surge from $1.08 billion in 2024 to about $1.23 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.7%. The substantial growth of the previous phase is mainly due to various factors such as the outbreak and contamination incidents, enhanced public awareness, the expansion of the biotechnology sector, research and development endeavours, trends in the healthcare industry, and an increase in cell culture production.

In the forthcoming years, the mycoplasma testing market is projected to experience swift expansion. The market is forecasted to reach a value of $1.92 billion in 2029, with a compound annual growth rate (CAGR) of 11.7%. The predicted growth during this period can be ascribed to factors such as the need for quality assurance, emerging market needs, the progress of the biopharmaceutical sector, the increase in cell-based therapies, and the growth of the biotechnology industry. Dominant trends during the forecast period are likely to be regulatory standards and compliance, awareness and innovations in healthcare and diagnostics, preparedness for global pandemics, and the emergence of point-of-care testing, as well as market penetration in developing economies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4103

What Are the Major Segments in the Mycoplasma Testing Market?
The mycoplasma testing market covered in this report is segmented -

1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

Subsegments:
1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment
2) By Assay: Mycoplasma Assays (PCR-Based, Culture-Based), Qualitative Assays, Quantitative Assays
3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits for Cell Cultures, Sample Preparation Kits
4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

What Are The Driving Mycoplasma Testing Market Evolution?
The mycoplasma testing market's growth is projected to be fueled by the escalating occurrence of mycoplasma pneumonia. This respiratory infection is triggered by the bacteria Mycoplasma pneumoniae, making mycoplasma testing a critical tool for its diagnosis. These tests can detect Mycoplasma pneumoniae bacteria in respiratory samples, contributing to a prompt and precise detection of the infection, thereby allowing for suitable medical treatment and management. For example, the Centers for Disease Control and Prevention, a US-based government entity, reported an estimated 2 million cases of Mycoplasma pneumoniae infections annually within the United States as of December 2023. Consequently, the rising occurrence of mycoplasma pneumonia is largely responsible for propelling the expansion of the mycoplasma testing market.

Which Firms Dominate The Mycoplasma Testing Market Segments?
Major companies operating in the mycoplasma testing market include Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

What Trends Are Expected to Dominate the Mycoplasma Testing Market in the Next 5 Years?
Key market participants are undertaking strategic investments, including the introduction of inventive products, advancements in research and development, and tech innovations. This is gaining considerable attention in the mycoplasma testing market. To meet the needs of end-users and broaden their customer base in this competitive business landscape, companies are launching innovative products. For instance, SwiftDx, a biotech firm from the UK, introduced a fresh detection test for mycoplasma contamination in October 2022 using a PCR-based technique. The SwiftDx Mycoplasma Detection Kit, a lateral flow test, provides a quick and accurate method for mycoplasma detection without interfering with cell growth by using a small sample taken directly from the cell culture media supernatant. The results are presented in a simple, comprehensible format. After the third day of culture, the test shows high sensitivity and specificity with a detection threshold of less than 10 cfu/mL.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Is The Largest Region In The Mycoplasma Testing Market?
North America was the largest region in the mycoplasma testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Mycoplasma Testing Market?
2. What is the CAGR expected in the Mycoplasma Testing Market?
3. What Are the Key Innovations Transforming the Mycoplasma Testing Industry?
4. Which Region Is Leading the Mycoplasma Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.